Search the Newsreel

Viva Leisure Posts Record FY2026 Results and Unveils Meridium Global Tech Spin-Off

Viva Leisure Delivers Profit Surge and Announces First Dividend

Membership boom, share-price slump: why Viva Leisure (ASX:VVA) enters FY26 results week trading near its lows

Aviva’s H1 profit falls by 49%

UK insurer Aviva reported a 49% decline in profit to £418m for the first half of 2026 (H1 2026), while basic earnings per share fell by 44% to 12.2p. The company said this came as operating profit increased by 24% to £1.32bn, which it …

Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached

Vivani Medical has filed an 8-K report, attaching a slide presentation as Exhibit 99.1. This presentation was distributed to the investment community and at conferences, providing key information about the company. The company notes that the presentation reflects information only as of the filing …

Why Is Aviva (LSE:AV) Back in Focus as UK Dividend Stocks Face Market Uncertainty?

70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp

Chase Investment Counsel Corp has acquired 70,000 shares of Innoviva, Inc. (NASDAQ:INVA) for approximately $1.59 million, representing a new stake of about 0.09% in the company. Institutional ownership in Innoviva remains high at 99.12%, with firms like Vanguard Group and Arrowstreet Capital also increasing …

Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA)

Innoviva (INVA) recently reported a Q2 2026 net loss of US$83.42 million despite increased revenue, alongside completing a US$66.40 million share buyback. While the quarterly loss introduces volatility, the company's six-month figures show overall revenue and net income growth, suggesting a complex investment narrative …

Is Innoviva (INVA) A Bargain After Revenue Grew But Earnings Turned To Loss?

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold"

Wall Street Zen has upgraded Vivani Medical (NASDAQ:VANI) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $3.75. Analyst opinions are varied, with Lake Street Capital initiating coverage with a "buy" rating and a …

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …

Vivakor | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

This article states that Vivakor has filed an NT 10-Q notice, indicating an inability to timely file all or part of a form 10-Q or 10-QSB. This notice is filed under Rule 12b25. The content explicitly states "Document," implying the document itself is the …

Vivakor (VIVK) delays Q2 2026 10-Q but signals higher revenue and lower loss

Aviva boss urges Chancellor to clamp down on pre-budget policy rumours

The boss of insurer Aviva has urged the new Chancellor not to "fly kites" with prospective policies ahead of the October budget after last year's speculation around pension changes. Chief executive Dame Amanda Blanc said widespread rumours that the Government might cut or restrict …

Viva Energy (ASX:VEA) Surges to Lead Gains Among Energy Stocks

Viva Biotech Sets Board Meeting to Approve Interim Results and Mull Dividend

Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA

Bank of America Corp DE increased its stake in Innoviva, Inc. (NASDAQ:INVA) by 6.6% in the first quarter, now owning 1,619,994 shares valued at approximately $37.75 million. Institutional investors and hedge funds collectively own 99.12% of Innoviva, and the stock currently has an average …

Aviva earnings jump by 24% amid swift progress on Direct Line turnaround

Insurer Aviva has seen half-year earnings surge by nearly a quarter as it cheered action to "quickly" improve profitability at Direct Line since buying the firm in a £3.7 billion deal. The group reported a better-than-expected 24% surge in operating profits to £1.33 billion …

Vivakor Pursues Critical Minerals Push With M2i Global Merger Talks

Vivakor Inc and M2i Global Inc have signed a non-binding indication of interest to explore a business combination focused on commodities trading, remediation, and critical minerals. The proposed deal involves an equity-exchange acquisition of M2i by Vivakor, with an initial 30-day negotiation period. This …

Vivakor | 8-K: Current report

This document is an 8-K current report filed by Vivakor. The 8-K form is used by public companies to announce significant events that investors should know about. Without further content, the specific nature of this significant event is unknown.

Form 8K Vivakor Inc For: 13 August By Investing.com

This article reports on Vivakor Inc.'s Form 8K filing for August 13. The company, trading under the symbol VIVK, experienced a slight dip in its stock performance. The content primarily serves as a notice of the filing and a brief update on the stock's …

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …

Vivani Medical: Q2 Earnings Snapshot

Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027

Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …

Form 8K Vivani Medical Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …

20 Participants Dosed in Semaglutide Trial; Data Due in November

Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …

Vivakor and M2i Global Announce Strategic Collaboration to Advance U.S. Critical Minerals Supply Chain

Vivakor, Inc. and M2i Global, Inc. have entered into an Indication of Interest to explore a potential business combination. The collaboration aims to strengthen the U.S. critical minerals supply chain and advance domestic mineral independence. This strategic move could expand Vivakor's commodities marketing and …

M2i Global and Vivakor sign deal to explore merger to boost US critical minerals supply chain

M2i Global Inc and Vivakor Inc have signed a non-binding agreement to explore a merger. The proposed deal aims to combine M2i's critical minerals platform with Vivakor's commodities marketing and remediation businesses to create a larger US-focused platform. This merger is intended to strengthen …

Vivakor and M2i Set 30-Day Window to Explore Critical Minerals Deal

Vivakor (Nasdaq: VIVK) and M2i Global (OTCQB: MTWO) have signed an Indication of Interest (IOI) to explore a potential business combination and strategic collaboration focused on advancing the U.S. critical minerals supply chain. The IOI outlines an initial 30-day period for negotiating valuation, transaction …

EXCLUSIVE: Vivakor Targets Critical Minerals Expansion Through Potential M2i Acquisition

Vivakor Inc. (NASDAQ: VIVK) and M2i Global Inc. (OTCQB: MTWO) have signed a non-binding indication of interest to explore a potential business combination. This proposed merger aims to expand Vivakor's operations into critical minerals, support the U.S. critical minerals supply chain, and combine their …

Aviva (LSE:AV.) Tests Whether link between diversified insurance earnings and shareholder distributions Can Endure

HC Wainwright Issues Positive Forecast for Innoviva Earnings